FDA Requests Bleeding Reports on Pradaxa Use

In a news release, the US Food and Drug Administration (FDA) requested post-marketing reports on bleeding incidents related to the use of Pradaxa. Pradaxa is a blood-thinning drug known for reducing the risk of stroke in patients. Many drugs may have some minor side effects, but side effects like diarrhea, heartburn, indigestion, mild stomach pain and nausea may be seen when using Pradaxa. FDA has also received reports of serious bleeding events in patients taking Pradaxa (dabigatran etexilate mesylate). These bleeding incidents may relate to some fatal outcomes. All of the patients currently taking Pradaxa and healthcare professionals that have prescribed it are requested to inform the FDA regarding these incidents at once.

As a Federal Way personal injury lawyer, I think it’s imperative to keep a close watch on the news coming from the FDA to aid in preventing avoidable injury. If you’ve suffered adverse health effects through the use of a defective medication, it may be in your best interests to speak with an experienced personal injury lawyer in your town.